STAT3 and acute myeloid leukemia: ,51 To develop viable therapeutic strategies targeting cell-cell communications between niche cells and AML cells, we should identify the pivotal candidate factors downstream of IL-6R/JAK/STAT3 signaling in AML cells that could not only stimulate mTORC1 activity in osteoblasts but also remodel the osteoblastic niche to favor AML progression.